Curative Biotechnology, Inc. Share Price Other OTC
Equities
CTYX
US20786Q2093
Biotechnology & Medical Research
Sales 2020 | - | Sales 2021 | - | Capitalization | 29.41M 2.36B |
---|---|---|---|---|---|
Net income 2020 | -4M -321M | Net income 2021 | -5M -401M | EV / Sales 2020 | - |
Net Debt 2020 | 399K 32M | Net cash position 2021 | 670K 53.74M | EV / Sales 2021 | - |
P/E ratio 2020 |
-2.11
x | P/E ratio 2021 |
-1.44
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.95% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 10/02/21 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 11/05/22 |
Theresa Heah
BRD | Director/Board Member | 46 | 03-30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |